The primary endpoint (the composite of death, disabling stroke, serious bleeding or cardiac arrest) based on ITT analysis at 48 months for PVI versus drug therapy was 8 percent versus 9.2 percent (HR 0.86, 95 percent CI 0.65-1.15; P = 0.303 NS).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.